CFI-402257 |
CFI-402257 : ATP competitive inhibitor of TTK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TTK |
|
|
Inhibitor
10-100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Tested against a panel of human kinases at 1 μM: CFI-402257 inhibited none. The molecule is an in ...
Potency Cellular
In Vitro
TTK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1073/pnas.1700234114
In Vivo Validations
Rat, Dog, Mouse
Dose: 1 mg/Kg IV, 5 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
2-3 h (M)
Systemic clearance:
22 (R), 7.9 (D) mL/min/kg
DOI Reference: 10.1073/pnas.1700234114
Chemical Information
| Molecular Formula | C28H30N6O3 |
| SMILEs | Cc1cc(-c2cnn3c(NC[C@H]4C[C@@](C)(O)C4)cc(Oc4cccnc4)nc23)ccc1C(=O)NC1CC1 |
| InChI | InChI=1S/C28H30N6O3/c1-17-10-19(5-8-22(17)27(35)32-20-6-7-20)23-16-31-34-24(30-14-18-12-28(2,36)13-18)11-25(33-26(23)34)37-21-4-3-9-29-15-21/h3-5,8-11,15-16,18,20,30,36H,6-7,12-14H2,1-2H3,(H,32,35)/t18-,28+ |
| Molecular weight | 498.24 Da |
| AlogP | 4.357120000000002 |
| HBond acceptors | 9 |
| HBond donors | 3 |
| Atoms | 67 |